Howard Young is the vice president of finance at LifeMine Therapeutics, where he leads the finance functions and strategic financial planning.

Howard has more than 15 years of experience in strategic planning, finance, accounting, and operating roles at life science companies in various stages of development. Prior to LifeMine, Howard was executive director of finance at Boston Biomedical (a subsidiary of Sumitomo Dainippon Pharma), where he established the initial financial operations activities, and corporate and portfolio planning capabilities.  Before that, he held positions of director of finance for ERP reimplementation and director of commercial finance with Vertex Pharmaceuticals, where he was the finance lead for the product portfolio team and a financial system rebuild.  In addition, Howard has also consulted to pharmaceutical companies and institutional investors on topics ranging from M&A to portfolio strategy and product launch.

Howard has an M.B.A. from the Tuck School of Business at Dartmouth College, and an A.B. from Middlebury College.